one random thought I have is assuming good trial results we are...

one random thought I have is assuming good trial results we are all expecting a significant rerate. they will at some point raise some capital for the next stages (ema, fda phase 3 and dfu pilot study). I kind of hope though that they let the dust settle following the results before going in to this raise. in some respects with the last raise after monitoring the share price decline I felt it was ready to climb significantly (many more buyers than sellers), and in fact it started to jump (from 0.041 to 0.0.47) which at the time I was hoping was the start of a rerate, but they then announced a capital raise at 0.04 which instantly killed the momentum for the next two months...

I guess what I'm saying is hopefully they don't announce results then a capital raise the next day. let the results sink in, firm up the forward plans, then go back to the market for funds..